Glenmark Pharmaceutical has informed that it attached media release titled ‘Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial’.
The above information is a part of company’s filings submitted to BSE.